Candel Therapeutics • CADL
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Paul Peter Tak, M.D.,PhD$161.4M
Market Cap • 18/04/20242003
(há 21 anos)
2021
(3 years ago)
NASDAQ
Listagem
Needham
Sede • Massachusetts76
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CADLSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.